Latest filing published 20 Apr 2017 for Cipher Pharmaceuticals Inc., €1,914.
This profile gathers the share dealings of Thomas Gordon Wellner in Cipher Pharmaceuticals Inc. We count 17 filings; the first trade dates from 18 January 2016 and the latest from 17 April 2017.
Every open-market trade on record is a sale: 1 sale. No amount is published for 1 filing, which the totals therefore leave out. The rest of the record consists of 14 share grants and 2 option exercises.
The newest entry dates from 20 April 2017: a share grant of €1,914, in Cipher Pharmaceuticals Inc. Between a trade and the moment it shows up on SEDI, the median delay is 4 days. This delay matters because a trade only becomes useful information once it is public. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
17 of 17 declarations